Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

Identifying Poor Prognosis in CDTalking Heads
Year: 2019
Authors: Mathieu Allez, Tim Raine
Immunological effects of nutritional interventions in IBD4th D-ECCO Workshop
Year: 2019
Authors: Dror Shouval
Interactive video presentation6th ECCO-ESGAR Ultrasound Workshop - Advanced
Year: 2019
Authors: Rune Wilkens
Interactive video presentation6th ECCO-ESGAR Ultrasound Workshop - Advanced
Year: 2019
Authors: Giovanni Maconi
Interactive video presentation 16th ECCO-ESGAR Ultrasound Workshop - Advanced
Year: 2019
Authors: Torsten Kucharzik
Interactive video presentation 26th ECCO-ESGAR Ultrasound Workshop - Advanced
Year: 2019
Authors: Stephan Vavricka
Is early use of biologic agents cost-effective in Crohn’s disease?JCC Podcast
Year: 2019
Authors: Nadia Pillai et al.

Fascinating results from Nadia Pillai, using real world data from a Swiss IBD cohort to model the cost-effectiveness of early biologic therapy. Early use of biologics is not cost effective in this cohort, but this outcome changes with biologic price drops or with more careful patient selection.

Laparascopic subtotal colectomy for Acute Colitis8th S-ECCO IBD Masterclass
Year: 2019
Authors: Janindra Warusavitarne
Lecture: Faecal diversion in severe anoperineal Crohn's Disease: Does it really work?8th S-ECCO IBD Masterclass
Year: 2019
Authors: Yves Panis
Lecture: Pregnancy and delivery in IBD patients8th S-ECCO IBD Masterclass
Year: 2019
Authors: Hagit Tulchinsky
Long side-to-side stricturoplasty8th S-ECCO IBD Masterclass
Year: 2019
Authors: Fabrizio Michelassi
Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn’s Disease Who Failed Biologic Therapies: A National Cohort StudyJCC Podcast
Year: 2019
Authors: Claire Liefferinckx et al.

Claire Liefferinckx discusses her work with the Belgian Inflammatory Bowel Disease research and development group (BIRD) to capture real-world outcomes of ustekinumab treatment for Crohn’s disease, using a large national cohort of patients with a history of significant previous biologic exposure.

Management of IBD outside of Europe: The example of IndiaScientific Programme
Year: 2019
Authors: Rupa Banerjee
Managing Refractory ProctitisTalking Heads
Year: 2019
Authors: Ailsa Hart, Janneke van der Woude
Mechanisms of Future DrugsTalking Heads
Year: 2019
Authors: Gionata Fiorino, Iris Dotan
Mechanisms of immune modulation by a topical TLR9 agonist in colitisJCC Podcast
Year: 2019
Authors: Heike Schmitt et al.

Heike Schmitt describes her work dissecting the immunomodulatory effects of cobitolimod using material from murine studies and a human clinical trial.

Metabolic profiling - the new player in microbiome researchScientific Programme
Year: 2019
Authors: Stefan Schreiber
Microencapsulated Sodium Butyrate significantly modifies the microbiota in patients with Inflammatory Bowel Disease mimicking prebiotic activity and proving effects on the treatment of the disease4th D-ECCO Workshop
Year: 2019
Authors: Sonia Fachhin
Molecular sub-classification of small bowel Crohn’sJCC Podcast
Year: 2019
Authors: Alka Potdar et al.

Dr Alka Potdar and Dr Janine Bilsborough discuss their paper analysing genetic and transcriptomic sub-classifiers of small bowel Crohn’s and the associated phenotypic characteristics.

https://academic.oup.com/ecco-jcc/pages/podcast 


Multi-omics profiling of IBDScientific Programme
Year: 2019
Authors: Jonas Halfvarson